companydata.dkcompanydata.dk

FLUIMEDIX ApS: Financial statements 2024

CVR: 27021689

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

FLUIMEDIX ApS (CVR 27021689) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -56,321 and a net result of DKK -64,901 compared with DKK -80,655 the year before. Equity in the 2024 report amounted to DKK 237,871. The solvency ratio was 73.5%. The company had 1 employee in the financial year.

Gross Profit
DKK -56,321
Profit/Loss
DKK -64,901
Equity
DKK 237,871
Total Assets
DKK 323,816
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--56 t.-65 t.238 t.1
2023-244 t.-81 t.303 t.1
2022--89 t.-364 t.383 t.1
2021--1 t.-279 t.747 t.1
2020--182 t.-254 t.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

FLUIMEDIX ApS: The 2023 annual report is outJun 7, 2024

FLUIMEDIX ApS has published its annual report for 2023. Gross profit came to DKK 244,180, and the net result was DKK -80,655.

About FLUIMEDIX ApS

FLUIMEDIX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2003. The company is registered under the industry Anden teknisk rådgivning. The management consists of Tomas Ussing. The board consists of Rolf Bertil Ehrnström, Rolf Singer, Sissel Mygind Trap and Steen Hansen. The company is owned by OPFINDER HOLDING AF 2003 ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 12,224 and a net result of DKK 17,955 compared with DKK -64,901 the year before. Equity in the 2025 report amounted to DKK 255,826.

Source: annual report 2025, Danish Business Authority